$0 Copay Program Effectively Improved Glycemic Control | ADA 2025
Drug Topics
JUNE 24, 2025
Researchers explored the impact of a $0 copay program on hemoglobin A1c levels in patients with type 2 diabetes who were also insured by Blue Cross and Blue Shield of Louisiana.
Let's personalize your content